Target intelligence / Profile preview

Axin2 (Axis inhibition protein 2) (Axin2)

Target
Axin2
Molecular classification
Scaffolding protein, Component of the β-catenin destruction complex, Tumor suppressor
01

Overview

Axin2, also known as Conductin or Axil, is a scaffolding protein and a core component of the β-catenin destruction complex, which negatively regulates the canonical Wnt signaling pathway. It promotes the phosphorylation and subsequent degradation of β-catenin, thereby limiting Wnt pathway activity. Axin2 is induced by Wnt signaling, likely forming a negative feedback loop to fine-tune Wnt responses. It interacts with APC, GSK3, CK1, and β-catenin to coordinate the sequential phosphorylation of β-catenin, marking it for degradation. Mutations in the AXIN2 gene are associated with colorectal cancer, indicating its role as a tumor suppressor. Structurally, Axin2 contains a GSK3-binding domain (GBD) that mediates interactions with the E3 ubiquitin ligase SIAH1, which regulates Axin2 degradation. Although Axin1 and Axin2 perform similar functions, their expression patterns and some molecular interactions differ, suggesting non-redundant roles in certain contexts. The target name "Long noncoding RNA A33/Axin2/β-catenin" is incorrect; Axin2 is a protein-coding gene, not a long noncoding RNA.

Other names
ConductinAxilAxis inhibition protein 2
02

Biological functions

Negative regulation of Wnt/β-catenin signalingScaffolding for β-catenin destruction complexSequential phosphorylation and degradation of β-cateninFeedback inhibition of Wnt signalingRole in embryonic developmentRole in organogenesisTumor suppression
03

Disease associations

Cancer (colorectal carcinoma, hepatocarcinoma)Role in embryogenesisRole in organogenesis
04

Safety considerations

Theoretical off-target effects due to pathway importance in normal physiology

Beyond the preview

Go deeper on Axin2 (Axis inhibition protein 2) (Axin2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axin2 (Axis inhibition protein 2) (Axin2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call